MOESM3 of Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection

Additional file 3. IL-11 knockdown efficiency was verified by ELISA

MOESM2 of Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection

Additional file 2. Standard curve for IL-11 (A) and PEDV M gene (B)

MOESM5 of Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection

Additional file 5. Cell viability assay after different inhibitor treatments. Cell viability was determined by a CCK-8 assay after treatment of the Vero E6 cells with different inhibitor concentrations including S3I-201 for 24 h (A), LY294002 and MK-2206 2HCl for 2 h (B)

MOESM4 of Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection

Additional file 4. pIL-11 treatment and knockdown did not affect cell viability. (A) Cell viability was determined by CCK-8 assay after treatment of the Vero E6 cells with different concentrations of pIL-11 for 18 h. (B) NC and IL-11 KD Vero E6 cells were plated and culture to 70% confluent monolayers for the CCK-8 assay

MOESM1 of Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection

Additional file 1. shRNA targeting sequences against IL-11

Additional file 1 of Construction of high coverage whole-genome sequencing libraries from single colon crypts without DNA extraction or whole-genome amplification

Supplementary Material

Additional file 1 of Efficacy of natural products on premature ovarian failure: a systematic review and meta-analysis of preclinical studies

Additional file 1: Supplemental Table 1. Search strategies for PubMed, Web of Science, and Scopus. Supplemental Figure 1.1. Forest plots: effects of various natural products on the secondary outcome of CAT level. Supplemental Figure 1.2. Forest plots: effects of various natural products on the secondary outcome of GSH level. Supplemental Figure 1.3. Forest plots: effects of various natural products on the secondary outcome of GSH-Px level. Supplemental Figure 1.4. Forest plots: effects of various natural products on the secondary outcome of GC’s apoptosis. Supplemental Figure 1.5. Forest plots: effects of various natural products on the secondary outcome of TNF-a level. Supplemental Figure 1.6. Forest plots: effects of various natural products on the secondary outcome of IL-β level. Supplemental Figure 1.7. Forest plots: effects of various natural products on the secondary outcome of IL-6 level. Supplemental Figure 2.1. Sensitivity analysis of various natural products on the primary outcomes of follicular development. (A) counts of primordial follicles, (B) counts of primary follicles, (C) counts of secondary follicles, (D) counts of antral follicles, (E) counts of atretic follicles. Supplemental Figure 2.2. Sensitivity analysis of various natural products on the primary outcomes of ovarian function. (A) AMH, (B) E2, (C) FSH, (D) LH, (E) P. Supplemental Figure 2.3. Forest plots: subgroup analysis of the strains. (A) counts of primordial follicles, (B) counts of primary follicles, (C) counts of secondary follicles, (D) counts of antral follicles, (E) counts of atretic follicles, (F) AMH, (G) E2, (H) FSH, (I) LH, (J) P

Additional file 1 of Mechanical overloading-induced miR-325-3p reduction promoted chondrocyte senescence and exacerbated facet joint degeneration

Additional file 1: Figure S1. The efficiency of miR-325-3p inhibitor and mimic in chondrocytes and the effect of miR-325-3p inhibitor and mimic on Collagen II in vitro. (A) Quantitative PCR analysis of miR-325-3p in mouse chondrocytes treated with miR-325-3p inhibitor or NC-inhibitor. n = 3 per group. (B-C) Representative Collagen II (green) immunofluorescence staining and quantitative analysis in normal chondrocytes treated with miR-325-3p inhibitor or NC-inhibitor. n = 6 per group. Scale bar: 50 µm. (D) Quantitative PCR analysis of miR-325-3p in CTS-treated chondrocytes administrated with miR-325-3p mimic or NC-mimic. n = 3 per group. (E-F) Representative Collagen II (green) immunofluorescence staining and quantitative analysis in CTS-treated chondrocytes administrated with miR-325-3p mimic or NC-mimic. n = 6 per group. Scale bar: 50 µm. All data are shown as the mean ±standard deviation (SD). **P < 0.01. Figure S2. AAV-miR-325-3p OE alleviates catabolism and promotes anabolism of chondrocytes in vivo. (A) Representative immunohistochemistry images of Collagen II (top), Aggrecan (middle) and MMP13 (bottom) in LFJ cartilage in sham, AAV-NC-treated groups and AAV-miR-325-3p OE-treated groups after 10 weeks bipedal standing. (B-D) Quantitative analysis of Collagen II, Aggrecan and MMP13 in (A). Scale bar=50 μm. n=6 per group. All data are shown as the mean ±standard deviation (SD). **P < 0.01. Figure S3. The effect of NSC-207895 (p53 activator) on mechanical-stress chondrocytes after treated with miR-325-3p mimic. (A) Representative immunofluorescence images of Collagen II in mouse chondrocytes in different groups. (B) Quantitative analysis of Collagen II fluorescence intensity in (A). Scale bar=50 μm. n=6 per group. All data are shown as the mean ±standard deviation (SD). **P < 0.01. Figure S4. Symmetrical facet joint degeneration was observed in the bipedal standing mice model. (A-B) Representative histological images of left and right FJs (Facet Joints) with Hematoxylin-eosin (H&E) and Safranin O/Fast Green staining after 10 weeks standing in mice. (C) Quantitative analysis of Osteoarthritis Research Society International (OARSI) score in (B); Scale bar=50 μm. All data are shown as the mean ±standard deviation (SD). n=6 per group. All data are shown as the mean ±standard deviation (SD). ‘n.s.’ represents non-significant (two-tailed Student’s t-test)

Additional file 2 of Mechanical overloading-induced miR-325-3p reduction promoted chondrocyte senescence and exacerbated facet joint degeneration

Additional file 2: Table S1. Antibodies. Table S2. Sequences of mimic and inhibitor. Table S3. Primers for qRT-PCR

Additional file 2 of Hypoxia-treated adipose mesenchymal stem cell-derived exosomes attenuate lumbar facet joint osteoarthritis

Figure 1. Identification of normoxia and hypoxia treated ADSCs-Exo. (A) The flow chart of isolation protocols for Hyo-ADSCs-Exo and ADSCs-Exo; (B) Morphology of ADSCs-Exo derived from hypoxic and normoxic conditions, as assessed by TEM; (C) The size distribution of Hypo-ADSCs-Exo and ADSCs-Exo; (D) Western blotting demonstrated the presence of exosomal surface markers CD81, CD63, and TSG101 between ADSCs-Exo and Hypo-ADSCs-Exo. Figure 2 Schematic of lumbar spine instability (LSI) model establishment and diagram of timeline for examination postoperative among different treatment groups in vivo. (A) Schematic of lumbar spine instability (LSI) model establishment and diagram of timeline for examination postoperative among different treatment groups in vivo. (A) Schematic of LSI model establishment and red arrows indicate the facet joint osteoarthritis induced by LSI; (B) Group information and details; (C) Schedule time points for spinal pain tests, histological evaluation, immunohistochemi-stry, SR-FTIR, 3D X-ray microscopy analysis and immunofluorescence. Figure 3. Immunofluorescence of CGRP+ and exosomes uptake and quantitative analysis of spinal pain-related behavior tests among different treatment groups. (A-B) The hind-paw withdrawal frequency (PWF) responding to the Von-Frey filaments with 0.7 mN and 3,9 mN; (C) Pressure hyperalgesia of the lumbar spine. (D) Representative images of immunofluorescence of CGRP+ (A marker of nociceptor nerves, Red-Alexa Fluor® 594) in subchondral bone of LFJ in vivo under 40x objective lens in 4, 6 and 8 weeks. Scale bar, 100 µm. (E) Quantitative analysis of the percentage of CGRP + area in subchondral bone of LFJ. (F) Representative image of immunofluorescence of PKH26 labeled Hypo-ADSCs-Exo (PKH26+, Red) through tail vein administration in facet joint cartilage and subchondral bone of LFJ in vivo. The yellow arrows indicate that Hypo-ADSCs-Exo by administration of tail vein were internalized in cartilage zone and subchondral bone area. Scale bar, 100 µm. All images were captured under 40x objective lens. All data are shown as the mean ± standard deviation (SD). *p<0.05, **p<0.01, compared with PBS treated group mice, #p<0.05, ##p<0.01, compared with ADSCs-Exo mice. n.s., non-significant. n = 6 per group. Figure 4. Hypo-ADSCs-Exo protect lumbar facet joint cartilage from degradation. (A) Representative histological images of LFJ cartilage with Hematoxylin-eosin (H&E) and Safranin O/Fast Green (top two) at 8 weeks post operation. Representative immunohistochemistry images of Collagen II, Aggrecan (middle two), and matrix metallopeptidase 13 (MMP13) (bottom) of LFJ cartilage. All images were captured under 40x objective lens. Scale bar = 50 µm; (B) Semi-quantitative analysis of FJ OA scores of articular cartilages in (A); (C-E) Quantitative analysis of col II, Aggrecan, MMP-13 LFJ articular cartilage at 8 weeks post operation. All data are shown as the mean ± standard deviation (SD). n = 6 per group. **p<0.01, compared with PBS treated group mice, #p<0.05, ##p<0.01 compared with ADSCs-Exo mice. n = 6 per group. Figure 5. Hypo-ADSCs-Exo restores the contents of proteoglycans (PGs) and collagen in degenerative lumbar facet joint cartilage. (A) Synchrotron infrared imaging of lumbar facet joint showing the optical stereogram of the normal cartilage area; Scale bar, 20 µm (B) Representative infrared spectra. The absorption of the most important biomolecules is indicated. Red arrows point out the peaks of carbohydrate (1180 − 985 cm− 1) and amide I (1775 − 1590 cm− 1) which correlate with PGs and collagen respectively; (C) and (D) False-colored chemical mappings to record the distribution of PGs and collagen across cartilage area of lumbar facet joint according to their characteristic feature around 1805 cm− 1 and 1651 cm− 1 respectively. All chemical mappings were normalized to the same color scale for comparison purpose with red color representing the highest ratio and blue color the lowest ratio as shown below the figures; (E) Representative optical stereogram and chemical mappings of the collagen and PGs across cartilage area of lumbar facet joint among four groups; Optical images were captured under 32x objective lens. Scale bar, 20 µm (F-G) Quantitative analysis of PGs and collagen in (E). All data are shown as the mean ± standard deviation (SD). n = 6 per group. *p<0.05, compared with PBS treated group mice, #p<0.05, compared with ADSCs-Exo mice. Figure 6. Hypo-ADSCs-Exo preserved the subchondral bone microarchitecture in LFJ OA. (A) 3D reconstructed X-ray microscope images of sub-chondral bone surface of the superior articular process and (left panel) corresponding sagittal microstructure (right panel) among the control, PBS or ADSCs-Exo and Hypo-ADSCs-Exo treated groups. Scale bar = 200 µm; (B) – (G) Histomorphometry analysis of 3D images of the LFJ subchondral bone among four different groups. All data are shown as the mean ± standard deviation (SD). n = 6 per group. **p<0.01, compared with PBS treated group mice, #p<0.05, ##p<0.01, compared with ADSCs-Exo mice. Figure 7. Hypo-ADSCs-Exo sustained coupled subchondral bone remodeling of LFJOA and attenuated the aberrant H-type vessels formation in subchondral bone. (A) Osteocalcin (OCN) staining (left panel) and TRAP staining (middle panel) in the subchondral bone of LFJ among different groups. Arrows point out the positive staining. Representative immunofluorescence of CD31 (Green), and Endomucin (Red) for H type vessel in the subchondral bone of LFJ among four groups (right panel). All images were captured under 40x objective lens. Scale bar = 50 µm; (B-C) The statistical analysis of the ratio of OCN (B) and TRAP (C) positive cells in the subchondral bone of LFJ. (D) The statistical results of the double staining positive (CD31+ Endomucin+) cells in the subchondral bone of LFJ. All data are shown as the mean ± standard deviation (SD). n = 6 per group. **p<0.01, compared with PBS treated group mice, #p<0.05, ##p<0.01, compared with ADSCs-Exo mice. Figure S1 Hypo-ADSCs-Exo protect synovial inflammation of lumbar facet joint after LSI surgery. (A) Representative histological images of LFJ synovium with Hematoxylin-eosin (H&E) at 8 weeks post operation. All images were captured under 40x objective lens. Scale bar = 50 µm; (B) Quantitative analysis of synovial inflammation at 8 weeks post operation. All data are shown as the mean ± standard deviation (SD). n = 6 per group. *p<0.05, compared with PBS treated group mice, #p<0.05, compared with ADSCs-Exo mice. n = 6 per group